Sartorius Stedim Biotech S.A.
SRTOY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $824,644 | $745,000 | $744,600 | $751,300 |
| % Growth | 10.7% | 0.1% | -0.9% | – |
| Cost of Goods Sold | $442,062 | $400,300 | $388,300 | $435,000 |
| Gross Profit | $382,583 | $344,700 | $356,300 | $316,300 |
| % Margin | 46.4% | 46.3% | 47.9% | 42.1% |
| R&D Expenses | $35,173 | $32,100 | $39,200 | $37,100 |
| G&A Expenses | $0 | $51,500 | $39,700 | $52,400 |
| SG&A Expenses | $184,163 | $167,000 | $166,500 | $174,000 |
| Sales & Mktg Exp. | $0 | $115,500 | $126,800 | $121,600 |
| Other Operating Expenses | $0 | $16,600 | $9,300 | -$4,400 |
| Operating Expenses | $219,336 | $215,700 | $215,000 | $206,700 |
| Operating Income | $163,246 | $129,000 | $141,300 | $109,600 |
| % Margin | 19.8% | 17.3% | 19% | 14.6% |
| Other Income/Exp. Net | -$61,115 | -$36,400 | -$25,900 | -$68,700 |
| Pre-Tax Income | $102,131 | $92,600 | $115,400 | $40,900 |
| Tax Expense | $26,526 | $24,000 | $30,000 | -$5,400 |
| Net Income | $75,021 | $68,500 | $85,600 | $45,600 |
| % Margin | 9.1% | 9.2% | 11.5% | 6.1% |
| EPS | 0.008 | 0.069 | 0.088 | 0.047 |
| % Growth | -88.8% | -21.6% | 87.2% | – |
| EPS Diluted | 0.008 | 0.069 | 0.088 | 0.047 |
| Weighted Avg Shares Out | 9,729,983 | 992,754 | 972,727 | 967,773 |
| Weighted Avg Shares Out Dil | 9,729,983 | 992,754 | 972,727 | 967,773 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4,791 | $0 | $37,500 | -$21,400 |
| Interest Expense | $60,063 | $30,900 | $63,300 | $11,200 |
| Depreciation & Amortization | $92,198 | $77,900 | $77,400 | $80,600 |
| EBITDA | $254,393 | $201,400 | $256,200 | $132,700 |
| % Margin | 30.8% | 27% | 34.4% | 17.7% |